Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

…, G DeBoer, MJ Yaffe, SJ Messner, WS Meschino… - Jama, 2004 - jamanetwork.com
ContextCurrent recommendations for women who have a BRCA1 or BRCA2 mutation are to
undergo breast surveillance from age 25 years onward with mammography annually and …

De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes

…, JL Lauzon, AE Lin, GMS Mancini, WS Meschino… - Nature …, 2012 - nature.com
Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus
(MPPH) syndromes are sporadic overgrowth disorders associated …

[HTML][HTML] Phenotypic heterogeneity of genomic disorders and rare copy-number variants

…, JS McConnell, B Angle, WS Meschino… - … England Journal of …, 2012 - Mass Medical Soc
Background Some copy-number variants are associated with genomic disorders with
extreme phenotypic heterogeneity. The cause of this variation is unknown, which presents …

Molecular mechanism for duplication 17p11. 2—the homologous recombination reciprocal of the Smith-Magenis microdeletion

…, MA Withers, V Kimonis, AM Summers, WS Meschino… - Nature …, 2000 - nature.com
Recombination between repeated sequences at various loci of the human genome are known
to give rise to DNA rearrangements associated with many genetic disorders 1. Perhaps …

[HTML][HTML] International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

…, L Senter, S Armel, L Bordeleau, WS Meschino… - British journal of …, 2019 - nature.com
Background Women with a BRCA1 or BRCA2 mutation face high risks of breast and ovarian
cancer. In the current study, we report on uptake of cancer screening and risk-reduction …

[PDF][PDF] Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening …

…, M Horgan, JC Carroll, A Eisen, WS Meschino… - J Clin …, 2014 - cancercareontario.ca
Purpose The Ontario Breast Screening Program expanded in July 2011 to screen women
age 30 to 69 years at high risk for breast cancer with annual magnetic resonance imaging (MRI…

[HTML][HTML] Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 …

…, R Salim, T Huang, A Adank, J Zhang, WS Meschino… - The Lancet, 2022 - thelancet.com
Background Existing evidence on the effects of race and ethnicity on pregnancy outcomes is
restricted to individual studies done within specific countries and health systems. We aimed …

[HTML][HTML] BAFopathies' DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin–Siris and Nicolaides–Baraitser syndromes

…, DJ Callen, AM Innes, SM White, WS Meschino… - Nature …, 2018 - nature.com
Coffin–Siris and Nicolaides–Baraitser syndromes (CSS and NCBRS) are Mendelian disorders
caused by mutations in subunits of the BAF chromatin remodeling complex. We report …

Not on the face alone: perception of contextualized face expressions in Huntington's disease

…, WS Meschino, J Kennedy, S Grewal, S Esmail… - Brain, 2009 - academic.oup.com
Numerous studies have demonstrated that Huntington's disease mutation-carriers have
deficient explicit recognition of isolated facial expressions. There are no studies, however, which …

Genotype–phenotype analysis of the branchio‐oculo‐facial syndrome

…, WS Meschino, GR Mortier, S Parkash… - American Journal of …, 2011 - Wiley Online Library
Branchio‐oculo‐facial syndrome (BOFS; OMIM#113620) is a rare autosomal dominant
craniofacial disorder with variable expression. Major features include cutaneous and ocular …